NAD+ 500mg Peptide | Third-Party Tested | RemedyX Labs
Order NAD+ 500mg research peptide online from RemedyX Labs. Verified batch COAs confirm purity and identity. Secure checkout, competitive pricing, and fast shipping.
NAD+ (nicotinamide adenine dinucleotide) is a naturally occurring coenzyme central to cellular energy metabolism, studied in controlled laboratory models of mitochondrial function, enzyme activity, and cellular energy pathways. Every batch is independently tested by a third-party laboratory to confirm identity and purity, with batch-specific Certificates of Analysis (COA) available for full transparency. For laboratory research use only. Not for human or animal use. Not intended for diagnostic, therapeutic, clinical, or commercial use.
- Price: 49.00 USD
- In stock
- Purity: 99%+
- CAS Number: 53-84-9
- Molecular Formula: C21H27N7O14P2
- Molecular Weight: 663.4
- Specification: 500mg/vial
- Contents: Lyophilized Powder
- Appearance: White to Off-White
- Intended Use: Research Only
- SKU: RXL-SKU-0023
Cited Research
Role and Potential Mechanisms of Nicotinamide Mononucleotide in Aging
This review evaluates the potential mechanisms through which nicotinamide mononucleotide influences biological processes associated with the aging process.
PubMed
Oral Administration of Nicotinamide Mononucleotide Is Safe and Efficiently Increases Blood Nicotinamide Adenine Dinucleotide Levels in Healthy Subjects
Researchers assessed the effect of oral nicotinamide mononucleotide administration on blood NAD levels in healthy human subjects.
PubMed
Nicotinamide Adenine Dinucleotide Metabolism and Arterial Stiffness After Long-Term Nicotinamide Mononucleotide Supplementation: A Randomized, Double-Blind, Placebo-Controlled Trial
This randomized controlled trial examined the impact of long-term nicotinamide mononucleotide supplementation on NAD metabolism and arterial stiffness markers.
PubMed
Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men
This study evaluated the effects of oral nicotinamide mononucleotide administration on clinical parameters and metabolite levels in healthy Japanese men.
PubMed, 2020
Effects of nicotinamide mononucleotide on older patients with diabetes and impaired physical performance: A prospective, placebo-controlled, double-blind study
Researchers conducted a clinical study to assess the effects of nicotinamide mononucleotide on older patients with diabetes and impaired physical performance.
PubMed, 2022
Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men
Researchers examined how chronic nicotinamide mononucleotide supplementation affects blood NAD levels and muscle function in healthy older men.
PMC, 2022
CA1 Nampt knockdown recapitulates hippocampal cognitive phenotypes in old mice which nicotinamide mononucleotide improves
This study investigated whether nicotinamide mononucleotide could improve cognitive phenotypes in aging mice following the knockdown of the Nampt enzyme in the hippocampus.
PubMed, 2018
Nicotinamide mononucleotide, an intermediate of NAD+ synthesis, protects the heart from ischemia and reperfusion
Investigators evaluated the protective effects of nicotinamide mononucleotide, an NAD synthesis intermediate, on cardiac tissue subjected to ischemia and reperfusion.
PubMed, 2014
Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study
This randomized controlled trial measured the effects of nicotinamide mononucleotide on blood NAD levels, walking speed, and sleep quality in older adults.
PMC, 2024
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
The researchers studied the impact of nicotinamide mononucleotide supplementation on insulin sensitivity within the skeletal muscle of prediabetic women.
PubMed, 2021
Evaluation of safety and effectiveness of NAD and NADH supplementation in humans
Reviews human safety and efficacy evidence across NAD-related formulations.
PubMed, 2024
The Role of NAD+ in Regenerative Medicine
Summarizes NAD-restoration biology and early clinical translation.
PMC, 2021
NAD+ supplementation for anti-aging and wellness: clinical evidence and uncertainties
Concludes that biological activity is evident but clinical wellness outcomes remain inconclusive.
PubMed, 2026
Dietary Supplementation With NAD+-Boosting Compounds in Humans
Finds that precursors raise NAD-related metabolites, while functional outcome evidence remains inconsistent.
PubMed, 2023
Roles of NAD+ in Health and Aging
Reviews NAD biology, precursors and unresolved translation questions.
PubMed, 2024
NAD+ therapy in age-related degenerative disorders
Reviews therapeutic strategies aimed at restoring intracellular NAD+.
PubMed, 2020
Effects of NAD+ precursor supplementation on glucose and lipid metabolism in humans
Synthesizes clinical-trial results for NAD precursors and metabolic outcomes.
PubMed, 2022
Effects of NAD+ supplementation with oral nicotinamide riboside on vascular and cognitive function
Explores vascular and cognitive outcomes after nicotinamide riboside supplementation.
PubMed, 2025